While statins and antihypertensives are the cornerstones of cardiovascular management, a powerful tool for heart protection is often overlooked: vaccination. Emerging evidence confirms a robust "lung-heart connection," demonstrating that acute respiratory infections act as significant triggers for inflammation and plaque rupture, leading to myocardial infarction and stroke.
This session will invite pharmacists to reimagine the role of vaccines in cardiovascular prevention. We will examine the evidence positioning vaccination not merely as infection control, but as a vital intervention for cardiovascular and chronic disease risk reduction.
Attendees will review the latest data illustrating how vaccines can reduce all-cause mortality and cardiovascular events in high-risk populations. Finally, we will translate this evidence into practice, providing actionable strategies for pharmacists to bridge the gap between immunization services and chronic disease management, ensuring every patient's heart is protected during respiratory virus season.
 

Food Available in Session

Sponsored by Pfizer